Dr. Salah Mahmoudi

CO-FOUNDER, Advisor

Salah brings his expert knowledge of complex diseases to Norachem, and was instrumental in the choice of the specific targets by which Norachem was able to demonstrate mathematical superiority over competing approaches.

Salah is currently conducting research in cancer at Pfizer. He has published in numerous prestigious journals, such as Nature and Nature Cell Biology, on the interplay between aging, inflammation, and age-related diseases. He also owns a patent on his discovery that the WRAP53 protein is directly linked to the survival of cancer cells.

Salah received his Ph.D. in experimental oncology from Karolinska Institutet in Stockholm, Sweden.